關於非小細胞肺癌

  ABSTRACT 9071

Brigatinib in ALK+ crizotinib-refractory non–small cell lung cancer (NSCLC): Final results of the Phase 1/2 and ALTA trials

POSTER SESSION
Lung Cancer - Non-Small
Cell Metastatic

https://meetinglibrary.asco.org/record/200517/abstract


  ABSTRACT 9042

Brigatinib in Japanese patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC): First results from the J-ALTA tyrosine kinase inhibitor (TKI)-naive expansion cohort

POSTER SESSION
Lung Cancer - Non-Small
Cell Metastatic

https://meetinglibrary.asco.org/record/200468/abstract

  ABSTRACT 9014

Mobocertinib (TAK-788) in EGFR exon 20 insertion (ex20ins)+ metastatic NSCLC (mNSCLC): Additional results from platinum-pretreated patients (pts) and EXCLAIM cohort of phase 1/2 trial

POSTER SESSION
Lung Cancer - Non-Small
Cell Metastatic

https://meetinglibrary.asco.org/record/198352/abstract


  ABSTRACT 9098

Real-world response and outcomes in NSCLC patients with EGFR exon 20 insertion mutations

POSTER SESSION
Lung Cancer - Non-Small
Cell Metastatic

https://meetinglibrary.asco.org/record/200641/abstract

C-ANPROM/TW/BRI/0008 Jun2021